Cited by 119Treatment of Major DepressionCircadian rhythm and melatoninNeurotransmitter Receptor Influence on Behavior

A Circadian Genomic Signature Common to Ketamine and Sleep Deprivation in the Anterior Cingulate Cortex

Open access
Orozco-Solis, Ricardo, Montellier, Emilie, Aguilar-Arnal, Lorena, Sato, Shogo, Vawter, Marquis P., Bunney, Blynn G., Bunney, William E., Sassone-Corsi, Paolo·2017·Biological Psychiatry

Abstract

Background Conventional antidepressants usually require several weeks to achieve a full clinical response in patients with major depressive disorder, an illness associated with dysregulated circadian rhythms and a high incidence of suicidality. Two rapid-acting antidepressant strategies, low-dose ketamine (KT) and sleep deprivation (SD) therapies, dramatically reduce depressive symptoms within 24 hours in a subset of major depressive disorder patients. However, it is unknown whether they exert their actions through shared regulatory mechanisms. To address this question, we performed comparative transcriptomics analyses to identify candidate genes and relevant pathways common to KT and SD. Methods We used the forced swim test, a standardized behavioral approach to measure antidepressant-like activity of KT and SD. We investigated gene expression changes using high-density microarrays and pathway analyses (Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, Gene Set Enrichment Analysis) in KT- and SD-treated mice compared with saline-treated control male mice. Results We show that KT and SD elicit common transcriptional responses implicating distinct elements of the circadian clock and processes involved in neuronal plasticity. There is an overlap of 64 genes whose expression is common in KT and SD. Specifically, there is downregulation of clock genes including Ciart, Per2, Npas4, Dbp, and Rorb in both KT- and SD-treated mice. Conclusions We demonstrate a potential involvement of the circadian clock in rapid antidepressant responses. These findings could open new research avenues to help design chronopharmacological strategies to treat major depressive disorder.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2017.02.1176

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. [68]Chiba S 2006 Notch signaling in stem cell systems Stem Cells 24 2437 2447 16888285
  2. [78]Berger M Riemann D Höchli D Spiegel R 1989 The cholinergic rapid eye movement sleep induction test with rs-86: State or trait marker of depression? Arch Gen Psychiatry 46 421 428 2712660

Cited by

Sorted by citations

Authors
Orozco-Solis, R., Montellier, E., Aguilar-Arnal, L., Sato, S., Vawter, M. P., Bunney, B. G., Bunney, W. E., & Sassone-Corsi, P.
Affiliations
University of California, Irvine (US)
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2017-09
Volume
82
Issue
5
Pages
351-360
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2594064947
Cited by
119
References
78
Citations by year
2026: 12 · 2025: 18 · 2024: 6 · 2023: 8 · 2022: 13 · 2021: 18 · 2020: 14 · 2019: 20 · 2018: 8 · 2017: 2
FWCI
8.40
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • Novo Nordisk Fonden
  • National Institutes of Health
  • University of California, Irvine
  • National Institute of Mental Health (R01MH085801)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
ketamine, sleep deprivation, major depressive disorder, circadian clock, anterior cingulate cortex, rapid-acting antidepressants, clock genes, gene expression, neuroplasticity, chronopharmacology, forced swim test, antidepressant-like effects
MeSH terms
Animals, Antidepressive Agents, Depressive Disorder, Disease Models, Animal, Gyrus Cinguli, Ketamine, Male, Mice, Inbred C57BL, Sleep Deprivation, Gene Expression, Computational Biology, Microarray Analysis, Circadian Rhythm Signaling Peptides and Proteins, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review